Form 4: Gilead Sciences Director Sells Shares
Insider Transaction (Form 4)
Anthony Welters, a Director of Gilead Sciences, Inc., sold 18,000 shares of common stock on August 26, 2026.
Summary
- Option exercise/conversion: acquired 7,718 Common Stock at $60.67 ($468,251) on August 26, 2026; holds 20,612 after (Direct).
- Open-market sale: disposed of 3,118 Common Stock at $148.31 ($462,432) on August 26, 2026; holds 17,494 after (Direct).
- Open-market sale: disposed of 4,600 Common Stock at $148.82 ($684,590) on August 26, 2026; holds 12,894 after (Direct).
- Option exercise/conversion: acquired 10,282 Common Stock at $61.35 ($630,801) on August 26, 2026; holds 23,176 after (Direct).
- Open-market sale: disposed of 3,402 Common Stock at $148.24 ($504,296) on August 26, 2026; holds 19,774 after (Direct).
- Open-market sale: disposed of 6,880 Common Stock at $148.82 ($1,023,900) on August 26, 2026; holds 12,894 after (Direct).
- Option exercise/conversion: disposed of 7,718 Non-qualified Stock Option (Right to Buy) on August 26, 2026 (Direct).
- Option exercise/conversion: disposed of 10,282 Non-qualified Stock Option (Right to Buy) on August 26, 2026; holds 5,569 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,675,220 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Anthony Welters — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Option exercise/conversion | Common Stock | 7,718 | $61 | $468.3K | 20,612 |
| 2026-08-26 | Open-market sale | Common Stock | 3,118 | $148 | $462.4K | 17,494 |
| 2026-08-26 | Open-market sale | Common Stock | 4,600 | $149 | $684.6K | 12,894 |
| 2026-08-26 | Option exercise/conversion | Common Stock | 10,282 | $61 | $630.8K | 23,176 |
| 2026-08-26 | Open-market sale | Common Stock | 3,402 | $148 | $504.3K | 19,774 |
| 2026-08-26 | Open-market sale | Common Stock | 6,880 | $149 | $1.0M | 12,894 |
| 2026-08-26 | Option exercise/conversion | Non-qualified Stock Option (Right to Buy) | 7,718 | — | — | 0 |
| 2026-08-26 | Option exercise/conversion | Non-qualified Stock Option (Right to Buy) | 10,282 | — | — | 5,569 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Option exercise/conversion (7,718 shares) |
| 2026-08-26 | Open-market sale (3,118 shares) |
| 2026-08-26 | Open-market sale (4,600 shares) |
| 2026-08-26 | Option exercise/conversion (10,282 shares) |
| 2026-08-26 | Open-market sale (3,402 shares) |
| 2026-08-26 | Open-market sale (6,880 shares) |
| 2026-08-26 | Option exercise/conversion (7,718 shares) |
| 2026-08-26 | Option exercise/conversion (10,282 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., bearish, Anthony Welters
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.